“Ideas that matter,
since 1965.”
At a time when spending in just about every area of the federal government is coming under intense scrutiny and review, the latest edition of The Ripon Forum examines the importance of investing in health research and why is it critical that the United States remain a global leader in that regard.
Is There Room in American Politics for the Don Bacons of the World?
Bacon’s success is thanks to strong relationships in his district and his brand as a centrist, opposing his party line just often enough to win over voters who otherwise prefer Democrats.
Today’s Trade War: Hype vs. Reality
In 2018, President Trump proclaimed trade wars “are good and easy to win.” Now, six months into the President’s latest trade war, the results have proven to be anything but.
Saving Can-Do: How to Revive the Spirit of America
Howard’s concern these days – and the focus for much of his latest book – has less to do with the DOGE wrecking ball that has been tearing through Washington than the question of what comes next.
Kelly Ayotte’s Six Month Report Card
It has been roughly six months since Governor Kelly Ayotte was sworn into the corner office in New Hampshire. While it is still obviously early in her term, she remains popular and enjoys a double digit favorability rating as a Republican in a purple state that was also won by Kamala Harris. Her achievements in […]
America First in Health Research
The U.S. should commit itself to making the most of that next generation of healthcare and maintain our position as the world’s premier leader in medical breakthroughs.
America’s Pharmaceutical Supply Chain is in Crisis
The United States should never be dependent on the Chinese Communist Party for antibiotics and essential medicines. But that’s exactly the dangerous position we are in today.
Vaccines Lead to Better Health and Greater Productivity
The creation, development, and deployment of vaccines – a U.S. federal priority since the 1960s – has been one of the greatest health care achievements in history.
As of 2023, roughly 194 million American adults had at least one chronic condition, which cost our nation’s economy billions of dollars each year.
The best way to prevent the downstream effects of overprescribing is to prevent it in the first place. That also means a concerted effort to prevent overdiagnosis.
The Future of AI in Health Care: Moving at the Speed of Trust
For modernization to truly take hold, and for the adoption of artificial intelligence to be systematic and widespread, we need greater confidence in its safety and effectiveness.
Debate
Should the Government Control Drug Prices? No…
Most favored nation would further devastate drug research.
Debate
Should the Government Control Drug Prices? Yes…
The key to effectively constraining spending on drugs without stifling innovation is regulating drug prices wisely, with the goal of having reductions in funding concentrated in innovations that have the most limited prospects of increasing value to patients.
The Honorable Mike Castle, who was the sole representative of Delaware in the U.S. House of Representatives, passed away at the age of 86 on August 14, 2025.
Greg Murphy reflects on how his career as a doctor shapes his service as a Member of Congress.
-
In this edition
At a time when spending in just about every area of the federal government is coming under intense scrutiny and review, the latest edition of The Ripon Forum examines the importance of investing in health research and why is it critical that the United States remain a global leader in that regard.
-
Is There Room in American Politics for the Don Bacons of the World?
Bacon’s success is thanks to strong relationships in his district and his brand as a centrist, opposing his party line just often enough to win over voters who otherwise prefer Democrats.
-
Today’s Trade War: Hype vs. Reality
In 2018, President Trump proclaimed trade wars “are good and easy to win.” Now, six months into the President’s latest trade war, the results have proven to be anything but.
-
Saving Can-Do: How to Revive the Spirit of America
Howard’s concern these days – and the focus for much of his latest book – has less to do with the DOGE wrecking ball that has been tearing through Washington than the question of what comes next.
-
Kelly Ayotte’s Six Month Report Card
It has been roughly six months since Governor Kelly Ayotte was sworn into the corner office in New Hampshire. While it is still obviously early in her term, she remains popular and enjoys a double digit favorability rating as a Republican in a purple state that was also won by Kamala Harris. Her achievements in…
-
America First in Health Research
The U.S. should commit itself to making the most of that next generation of healthcare and maintain our position as the world’s premier leader in medical breakthroughs.
-
America’s Pharmaceutical Supply Chain is in Crisis
The United States should never be dependent on the Chinese Communist Party for antibiotics and essential medicines. But that’s exactly the dangerous position we are in today.
-
Vaccines Lead to Better Health and Greater Productivity
The creation, development, and deployment of vaccines – a U.S. federal priority since the 1960s – has been one of the greatest health care achievements in history.
-
The Cost of Chronic Disease
As of 2023, roughly 194 million American adults had at least one chronic condition, which cost our nation’s economy billions of dollars each year.
-
America the Overprescribed
The best way to prevent the downstream effects of overprescribing is to prevent it in the first place. That also means a concerted effort to prevent overdiagnosis.
-
The Future of AI in Health Care: Moving at the Speed of Trust
For modernization to truly take hold, and for the adoption of artificial intelligence to be systematic and widespread, we need greater confidence in its safety and effectiveness.
-
Should the Government Control Drug Prices? No…
Most favored nation would further devastate drug research.
-
Should the Government Control Drug Prices? Yes…
The key to effectively constraining spending on drugs without stifling innovation is regulating drug prices wisely, with the goal of having reductions in funding concentrated in innovations that have the most limited prospects of increasing value to patients.
-
Remembering Mike Castle
The Honorable Mike Castle, who was the sole representative of Delaware in the U.S. House of Representatives, passed away at the age of 86 on August 14, 2025.
-
Ripon Profile of Greg Murphy
Greg Murphy reflects on how his career as a doctor shapes his service as a Member of Congress.
★
Receive updates on latest commentary, and noteworthy news.